CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Sandoz Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 31, 2019
Approval ID: 6c2ed55a-c7f2-42be-a194-bd498707ce3f
Products: 1 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT safely and effectively. See full prescribing information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT. CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE ointment for topical useInitial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.